Permanently Farnesylated Prelamin A, Progeria, and Atherosclerosis.
作者信息
Worman Howard J, Michaelis Susan
机构信息
Department of Medicine and Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York (H.J.W.).
Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD (S.M.).
出版信息
Circulation. 2018 Jul 17;138(3):283-286. doi: 10.1161/CIRCULATIONAHA.118.034480.
Abstract
摘要
相似文献
1
Permanently Farnesylated Prelamin A, Progeria, and Atherosclerosis.
Circulation. 2018 Jul 17;138(3):283-286. doi: 10.1161/CIRCULATIONAHA.118.034480.
2
Accelerated atherosclerosis in HGPS.
Aging (Albany NY). 2018 Oct 21;10(10):2555-2556. doi: 10.18632/aging.101608.
3
Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12873-8. doi: 10.1073/pnas.0505767102. Epub 2005 Aug 29.
4
Protein farnesyltransferase inhibitors and progeria.
Trends Mol Med. 2006 Oct;12(10):480-7. doi: 10.1016/j.molmed.2006.08.006. Epub 2006 Aug 30.
5
Prelamin A and lamin A appear to be dispensable in the nuclear lamina.
J Clin Invest. 2006 Mar;116(3):743-52. doi: 10.1172/JCI27125.
6
Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
Circulation. 2013 Jun 18;127(24):2442-51. doi: 10.1161/CIRCULATIONAHA.112.000571. Epub 2013 May 20.
7
Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
J Clin Invest. 2016 Apr 1;126(4):1592-602. doi: 10.1172/JCI85908. Epub 2016 Mar 21.
8
Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2154-9. doi: 10.1073/pnas.0511133103. Epub 2006 Feb 6.
9
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
FEBS J. 2013 Dec;280(23):6223-32. doi: 10.1111/febs.12544. Epub 2013 Nov 18.
10
A mutation abolishing the ZMPSTE24 cleavage site in prelamin A causes a progeroid disorder.
J Cell Sci. 2016 May 15;129(10):1975-80. doi: 10.1242/jcs.187302. Epub 2016 Mar 31.
引用本文的文献
1
Skeletal phenotypes and molecular mechanisms in aging mice.
Zool Res. 2024 Jul 18;45(4):724-746. doi: 10.24272/j.issn.2095-8137.2023.397.
2
The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B.
Nucleus. 2023 Dec;14(1):2288476. doi: 10.1080/19491034.2023.2288476. Epub 2023 Dec 5.
3
Prelamin A and ZMPSTE24 in premature and physiological aging.
Nucleus. 2023 Dec;14(1):2270345. doi: 10.1080/19491034.2023.2270345. Epub 2023 Oct 26.
4
The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.
mBio. 2022 Oct 26;13(5):e0254322. doi: 10.1128/mbio.02543-22. Epub 2022 Oct 5.
5
Breaking the aging epigenetic barrier.
Front Cell Dev Biol. 2022 Jul 28;10:943519. doi: 10.3389/fcell.2022.943519. eCollection 2022.
6
A Multisensory Network Drives Nuclear Mechanoadaptation.
Biomolecules. 2022 Mar 4;12(3):404. doi: 10.3390/biom12030404.
7
Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice.
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9). doi: 10.1073/pnas.2118695119.
8
Nuclear membrane ruptures underlie the vascular pathology in a mouse model of Hutchinson-Gilford progeria syndrome.
JCI Insight. 2021 Aug 23;6(16):e151515. doi: 10.1172/jci.insight.151515.
9
ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
Am J Respir Cell Mol Biol. 2021 Sep;65(3):300-308. doi: 10.1165/rcmb.2020-0544OC.
10
Intermediate filaments as effectors of differentiation.
Curr Opin Cell Biol. 2021 Feb;68:155-162. doi: 10.1016/j.ceb.2020.10.009. Epub 2020 Nov 24.
本文引用的文献
1
Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Circulation. 2018 Jul 17;138(3):266-282. doi: 10.1161/CIRCULATIONAHA.117.030856. Epub 2018 Feb 28.
2
A mutation abolishing the ZMPSTE24 cleavage site in prelamin A causes a progeroid disorder.
J Cell Sci. 2016 May 15;129(10):1975-80. doi: 10.1242/jcs.187302. Epub 2016 Mar 31.
3
Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
J Clin Invest. 2016 Apr 1;126(4):1592-602. doi: 10.1172/JCI85908. Epub 2016 Mar 21.
4
Biochemistry. A protease for the ages.
Science. 2013 Mar 29;339(6127):1529-30. doi: 10.1126/science.1236764.
5
Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity.
Hum Mol Genet. 2012 Sep 15;21(18):4084-93. doi: 10.1093/hmg/dds233. Epub 2012 Jun 19.
6
Splicing-directed therapy in a new mouse model of human accelerated aging.
Sci Transl Med. 2011 Oct 26;3(106):106ra107. doi: 10.1126/scitranslmed.3002847.
7
Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging.
Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2301-9. doi: 10.1161/ATVBAHA.110.209460. Epub 2010 Aug 26.
8
Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging.
Circulation. 2010 May 25;121(20):2200-10. doi: 10.1161/CIRCULATIONAHA.109.902056. Epub 2010 May 10.
9
Laminopathies and the long strange trip from basic cell biology to therapy.
J Clin Invest. 2009 Jul;119(7):1825-36. doi: 10.1172/JCI37679. Epub 2009 Jul 1.
10
Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration.
Circ Res. 2008 Jun 20;102(12):1529-38. doi: 10.1161/CIRCRESAHA.108.175976. Epub 2008 May 22.
Zotero 插件